Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,922 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,922 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $5,922 | 2 | AstraZeneca Pharmaceuticals LP ($5,922) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/07/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $3,222.00 | General |
| Category: Oncology | ||||||
| 03/09/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,712 | 1,923 | $215,225 | $28,103 |
| 2022 | 7 | 1,991 | 2,192 | $288,377 | $38,275 |
| 2021 | 7 | 1,788 | 1,901 | $268,424 | $35,078 |
| 2020 | 7 | 2,438 | 3,023 | $352,570 | $48,931 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 232 | 239 | $80,065 | $8,534 | 10.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 66 | 66 | $31,416 | $4,199 | 13.4% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 487 | 654 | $23,544 | $4,159 | 17.7% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 359 | 383 | $16,469 | $2,684 | 16.3% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 64 | 67 | $25,058 | $2,554 | 10.2% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2023 | 47 | 47 | $8,460 | $2,221 | 26.3% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 291 | 301 | $15,953 | $2,022 | 12.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 123 | 123 | $7,187 | $942.79 | 13.1% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 17 | 17 | $5,695 | $614.97 | 10.8% |
| 76376 | 3d radiographic procedure | Office | 2023 | 26 | 26 | $1,378 | $173.52 | 12.6% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 318 | 323 | $108,205 | $11,627 | 10.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2022 | 89 | 90 | $42,840 | $5,995 | 14.0% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 113 | 125 | $46,750 | $4,804 | 10.3% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 420 | 554 | $19,944 | $3,667 | 18.4% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 401 | 432 | $18,576 | $3,345 | 18.0% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2022 | 66 | 66 | $11,880 | $3,338 | 28.1% |
| 76376 | 3d radiographic procedure | Facility | 2022 | 419 | 435 | $23,055 | $2,972 | 12.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 108 | 110 | $6,774 | $1,327 | 19.6% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 26 | 26 | $8,710 | $977.27 | 11.2% |
| 76376 | 3d radiographic procedure | Office | 2022 | 31 | 31 | $1,643 | $223.17 | 13.6% |
| 71250 | Diagnostic ct scan of chest | Facility | 2021 | 343 | 346 | $115,910 | $12,397 | 10.7% |
| 71275 | Ct scan of blood vessels in chest with contrast | Facility | 2021 | 66 | 66 | $31,416 | $4,493 | 14.3% |
| 71260 | Diagnostic ct scan of chest with contrast | Facility | 2021 | 106 | 112 | $41,888 | $4,448 | 10.6% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2021 | 68 | 68 | $12,240 | $3,415 | 27.9% |
| 76376 | 3d radiographic procedure | Facility | 2021 | 436 | 449 | $23,797 | $3,055 | 12.8% |
About Dr. Edward Patz, M.D
Dr. Edward Patz, M.D is a Diagnostic Radiology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720114234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Patz, M.D has received a total of $5,922 in payments from pharmaceutical and medical device companies, with $5,922 received in 2021. These payments were reported across 2 transactions from 1 company. The most common payment nature is "Consulting Fee" ($5,922).
As a Medicare-enrolled provider, Patz has provided services to 7,929 Medicare beneficiaries, totaling 9,039 services with total Medicare billing of $150,387. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Durham, NC
- Active Since 02/26/2007
- Last Updated 07/11/2023
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1720114234
Products in Payments
- TAGRISSO (Drug) $3,222
- IMFINZI (Biological) $2,700
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Durham
Dr. Rendon Nelson, M.d, M.D
Diagnostic Radiology — Payments: $1.7M
Daniele Marin, Md, MD
Diagnostic Radiology — Payments: $1.1M
Dr. Paul Suhocki, Md, MD
Diagnostic Radiology — Payments: $354,598
Rajan Gupta, M.d, M.D
Diagnostic Radiology — Payments: $185,794
Dr. David Enterline, M.d, M.D
Diagnostic Radiology — Payments: $113,728
Dr. Shelley Weiner, M.d, M.D
Diagnostic Radiology — Payments: $104,554